MedPath

a clinical study to evaluate the comparative effect of shatavari and ashwagandha on shukra kshaya

Not yet recruiting
Conditions
Oligospermia. Ayurveda Condition: shukra kshaya,
Registration Number
CTRI/2021/09/036415
Lead Sponsor
Government ayurvedic college patiala
Brief Summary

this study is randomized, open, parallel group, interventional type, single center trial comparing the efficacy of shatavari 3gms twice a day and ashwagandha 3gms twice a day for 90 days in 40 patients with shukra kshaya that will be conducted in single center in India. The primary outcome measures will be significantly different effects of shatavari and ashwagandha on shukra kshaya in 90 days. The secondary outcome measures will be no significantly different effects of shatavari and ashwagandha on shukra kshaya in 90 days trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • individuals giving written consent for the study.
  • marital status: married pt.
  • fulfilling the diagnostic criteria as per clinical performa.
Exclusion Criteria
  • individuals not giving written consent for the study.
  • having corticosteroids.
  • with azoospermia.
  • BMI>30kg/m2 pt.
  • anatomical disabilities of male reproductive organ like varicocele, hydrocele, absence or blockage of passage tubules.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
shatavari and ashwagandha possess significantly different effects on shukra kshaya.after 3 months
Secondary Outcome Measures
NameTimeMethod
shatavari and ashwagandha do not possess significantly different effects on shukra kshaya.after 3 months

Trial Locations

Locations (1)

Government Ayurvedic Hospital

🇮🇳

Patiala, PUNJAB, India

Government Ayurvedic Hospital
🇮🇳Patiala, PUNJAB, India
Shubham Bansal
Principal investigator
7589079611
dr.shubhambansal611@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.